Tivic Health Systems, Inc.
For the period ended Jun 30, 2025. Filed Aug 14, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Jun 30, 2025 · Filed Aug 14, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 1. Financial Statements
Our condensed financial statements included in this Quarterly Report on Form 10‑Q are as follows:
| Condensed Balance Sheets as of June 30, 2025 (unaudited) and December 31, 2024 | 2 |
|---|---|
| Condensed Statements of Operations for the three and six months ended June 30, 2025 and 2024 (unaudited) | 3 |
| Condensed Statements of Stockholders’ Equity for the three and six months ended June 30, 2025 and 2024 (unaudited) | 4 |
| Condensed Statements of Cash Flow for the six months ended June 30, 2025 and 2024 (unaudited) | 6 |
| Notes to Condensed Financial Statements (unaudited) | 7 |
This Quarterly Report on Form 10‑Q (this “Quarterly Report”) for the quarter ended June 30, 2025, should be read in conjunction with the Tivic Health Systems, Inc.’s Annual Report on Form 10‑K for the year ended December 31, 2024, filed with the Securities and Exchange Commission (the “SEC”) on March 21, 2025.
The accompanying condensed financial statements and footnotes have been prepared in accordance with accounting principles generally accepted in the United States of America for interim financial information and the SEC instructions to Form 10‑Q. In the opinion of management, all adjustments considered necessary for a fair presentation have been included. Operating results for the interim period ended June 30, 2025 are not necessarily indicative of the results that can be expected for the full year.
Condensed Balance Sheets
June 30, 2025 and December 31, 2024
(in thousands, except share and per share data)
| June 30, | December 31, | |
|---|---|---|
| 2025 | 2024 | |
| (Unaudited) | (Audited) | |
| ASSETS | ||
| Current assets | ||
| Cash and cash equivalents | $1,184 | $2,002 |
| Accounts receivable, net | 13 | 69 |
| Inventory, net | 283 | 319 |
| Prepaid expenses and other current assets | 362 | 249 |
| Total current assets | 1,842 | 2,639 |
| Property and equipment, net | 120 | 119 |
| Deferred offering costs | 301 | 49 |
| Licensed technology | 2,243 | — |
| Other assets | 2 | — |
| Total assets | $4,508 | $2,807 |
| LIABILITIES AND STOCKHOLDERS’ EQUITY | ||
| Current liabilities | ||
| Accounts payable | $234 | $125 |
| Other accrued expenses | 587 | 147 |
| Total current liabilities | 821 | 272 |
| Total liabilities | 821 | 272 |
| Commitments and contingencies (Note 8) | ||
| Stockholders’ equity | ||
| Preferred stock, $0.0001 par value, 10,000,000 shares authorized; 1,191 shares issued and outstanding at June 30, 2025 and no shares issued and outstanding at December 31, 2024 | — | — |
| Common stock, $0.0001 par value, 200,000,000 shares authorized; 965,899 and 556,902 shares issued and outstanding at June 30, 2025 and December 31, 2024, respectively | 1 | 1 |
| Additional paid in capital | 50,661 | 46,075 |
| Accumulated deficit | (46,975) | (43,541) |
| Total stockholders’ equity | 3,687 | 2,535 |
| Total liabilities and stockholders’ equity | $4,508 | $2,807 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.